Policy relevant Results from an Expert Elicitation on the Human Health Risks of Decabromodiphenyl ether (decaBDE) and Hexabromocyclododecane (HBCD)

Environmental Health

Methodology

Karin E Zimmer¹  Arno C Gutleb²  Erik Ropstad³  Jan L Lyche⁴  Janna G Koppe⁵  Aileen Yang⁶  Alena Bartonova⁶  Michael Kobernus⁶  Janneche U Skaare⁷  Gunnar S Eriksen⁷  Solveig Ravnum⁸  Hans Keune⁹  Brooke Magnanti^1,10  Martin Krayer von Krauss^1,11  Albertinka J Murk^1,12 

[1] Department of Basic Sciences and Aquatic Medicine, Norwegian School of Veterinary Science, Department of Production Animal Clinical Science, P.O.Box 8146, 0033, Oslo, Norway;Department of Environment and Agro-biotechnologies (EVA), Centre de Recherche Public - Gabriel Lippmann, Department of Environment and Agro-biotechnologies (EVA), 41 rue du Brill, 4422, Belveaux, Grand-Duchy of Luxembourg;Department of Production Animal Clinical Science, Norwegian School of Veterinary Science, P.O.Box 8146, 0033, Oslo, Norway;Department of Production Animal Clinical Science, Norwegian School of Veterinary Science, P.O.Box 8146, 0033, Oslo, Norway;Department of Food Safety and Infection Biology, Norwegian School of Veterinary Science, P.O.Box 8146, 0033, Oslo, Norway;EcoBaby Foundation, Hollandstraat 6, 3634 AT, Loenersloot, The Netherlands;NILU - Norwegian Institute of Air Research, P.O.Box 100, 2027, Kjeller, Norway;Norwegian Veterinary Institute, P.O.Box 750, 0106, Oslo, Norway;Norwegian Veterinary Institute, P.O.Box 750, 0106, Oslo, Norway;NILU - Norwegian Institute of Air Research, P.O.Box 100, 2027, Kjeller, Norway;Research Institute for Nature and Forest (INBO), Brussels; Centre of Expertise for Environment and Health, Faculty of Political and Social Sciences, University of Antwerp; naXys, Namur Center for Complex Systems, University of Namur, Belgium;University Hospital, Biophysics group, St. Michael’s Hospital, Southwell Street, BS2, 8EJ, Bristol, UK;WHO, Regional Office for Europe, Scherfigs vej 8, 2100, Copenhagen Ø, Denmark;Wageningen University, Section of Toxicology, P.O. Box 6700, Wageningen, EA, The Netherlands;Wageningen-IMARES, 1976CP, IJmuiden, The Netherlands;

关键词: Phthalate;    Health Impact Assessment;    Brominate Flame Retardant;    Expert Elicitation;    Human Epidemiological Study;   

DOI  :  10.1186/1476-069X-11-S1-S7

来源: Springer

【 摘 要 】

AimApply a recently developed expert elicitation procedure to evaluate the state of the current knowledge of the two brominated flame retardants (BFRs) most commonly used today; decabromo-diphenyl ether (decaBDE) and hexabromocyclododecane (HBCD) and their potential impact on human health in order to support policy considerations. This expert elicitation was organized by the HENVINET (Health and Environment Network) Consortium.MethodThe HENVINET expert elicitation procedure that was used in the evaluations of decaBDE and HBCD is a rapid assessment tool aimed at highlighting areas of agreement and areas of disagreement on knowledge-related key issues for environment and health policy decision making.ResultsThe outcome of the expert consultation on BFRs was concrete expert advice for policy makers with specific priorities for further action made clear for both stakeholders and policy makers. The experts were not in agreement whether or not the knowledge currently available on decaBDE or HBCD is sufficient to justify policy actions, but most experts considered that enough data already exists to support a ban or restriction on the use of these compounds. All experts agreed on the necessity of more research on the compounds. Priority issues for further research were, among others:• more studies on the extent of human exposure to the compounds.• more studies on the fate and concentration in the human body of the compounds.

【 授权许可】

CC BY   
© Ravnum et al; licensee BioMed Central Ltd. 2012